Inogen Inc (INGN) company profile
Close on Nov 17, 2026Market cap $150.87MP/E –Yield –
About Inogen
Orthopedic, Prosthetic & Surgical Appliances & Supplies, SIC 3842
Inogen, Inc. is a medical technology company that develops, manufactures, and distributes respiratory health products. Its core offerings include portable oxygen concentrators such as the Inogen One and Inogen Rove systems, designed to deliver supplemental long-term oxygen therapy while allowing patient mobility. The company also distributes stationary oxygen concentrators, CPAP masks for obstructive sleep apnea, and the Simeox airway clearance device for mucus management. Inogen serves patients with chronic respiratory conditions such as chronic obstructive pulmonary disease, cystic fibrosis, and bronchiectasis. The business delivers products directly to patients through direct-to-consumer sales and rentals, while also supplying home medical equipment providers, distributors, resellers, and clinical facilities.
The company distributes its products in the United States and has sold into 70 countries internationally. Inogen operates an engineering and design location in Goleta, California, and maintains an assembly facility in Plano, Texas. Internationally, the firm maintains a customer service center in the Netherlands, conducts device manufacturing in Montpelier, France, and utilizes contract manufacturing services in the Czech Republic.
Summary of the business section of Inogen's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Inogen Inc
- Founded
- 2001
- Headquarters
- Beverly, MA
- Address
- 500 Cummings Center, Suite 2800 01915
- Phone
- (805) 562-0500
- Website
- inogen.com
- Employees
- 314, Dec 31, 2025
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Deloitte & Touche LLP, Los Angeles, California, USA
Stock & identifiers
- Ticker
- INGN
- Exchange
- Nasdaq
- IPO date
- Feb 14, 2014
- Shares outstanding
- 27M, Aug 1, 2026
- Public float
- $190.10M, Jun 30, 2025
- Filer category
- Accelerated filer<br>Smaller reporting company
- SEC CIK
- 1294133
- CUSIP
- 45780L104
- ISIN
- US45780L1044
- FIGI
- BBG0021PH456
- Share class FIGI
- BBG0021PH465
- LEI
- 549300J8WJIVTOJ8IH97
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Kevin Raymond Merrill Smith | CEO and President, Director | 134,962 |
| Kevin P. Smith | EVP, Bus Dev, GC & Sec | 23,507 |
| Mary E. Wright | VP, Chief Accounting Officer | 20,629 |
| Andrew P. Reding | EVP, COO | – |
| Boyer Jennifer M. Yi | EVP Entrprs Enblmnt, Ch HR Off | 5,039 |
| Jason Andrew Richardson | EVP, CFO & Treasurer | – |
| Michael J. Bourque | EVP, CFO & Treasurer | 94,557 |
| Gregoire Ramade | Chief Commercial Officer | 44,229 |
| Elizabeth Mora | Director | 107,261 |
| Glenn S. Boehnlein | Director | 104,966 |
| Mary Kay Ladone | Director | 104,966 |
| Heather D. Rider | Director | 118,282 |
| Kevin M. King | Director | 104,966 |
| Mira Kirti Sahney | Director | 67,805 |
| Vafa Jamali | Director | 43,081 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $3.04M | $1.87M | $1.52M | $15 | $78 |
| FY2024 | $4.16M | $5.42M | $961.48K | $21 | $78 |
| FY2023 Kevin RMSmith | $1.80M | $1.73M | $1.08M | $12 | $74 |
| FY2023 Nabil Shabshab | $4.29M | -$1.36M | $1.08M | $12 | $74 |
| FY2022 | $6.27M | $3.24M | $2.04M | $44 | $79 |
| FY2021 | $7.04M | $5.61M | $1.22M | $76 | $103 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Stock awards | Incentive pay | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|
| Kevin R.M. Smith Chief Executive Officer and President, Director | $711.08K | $1.87M | – | $28.18K | $2.61M | -37% |
| Michael Bourque Former Executive Vice President, Chief Financial Officer, and Corporate Treasurer (16) | $450.11K | $1.06M | $162.04K | $34.23K | $1.71M | -9% |
| Kevin P. Smith General Counsel & EVP Business Development | $432.52K | $874.77K | $129.76K | $25.97K | $1.46M | +50% |
| Gregoire Ramade Executive Vice President, Chief Commercial Officer | $447.35K | $812.29K | $158.20K | $1.23K | $1.42M | +63% |
| Jennifer Yi Boyer Executive Vice President, Enterprise Enablement and Chief Human Resources Officer | $426.69K | $812.29K | $128.01K | $102.40K | $1.47M | – |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
IPO
From the final prospectus (Form 424B4) and the first day of trading
Offering
- Type
- Initial public offering
- Final prospectus filed
- Feb 14, 2014
- Offer price
- $16.00
- Securities offered
- 4,411,763
- Gross proceeds
- $70.59M
- Exchange
- Nasdaq
- Lock-up ends (est.)
- Aug 13, 2014
“The initial public offering price is $16.00 per share.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we employed 314 people in the United States in our Sales and Marketing organization.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Nov 5, 2026 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Sep 18, 2023 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Apr 7, 2021 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Aug 9, 2019 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Aug 20, 2015 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Apr 20, 2015 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Apr 1, 2015 | Late filing | Notification of late filing |
| Feb 14, 2014 | IPO | Initial public offering priced (424B4 prospectus) |
| Feb 10, 2014 | Listing | Registration of securities on an exchange (Form 8-A) |
See a number that looks wrong?